Evidence map›Paper›PMID 40406669›Full record

ArticleBioinformatics advances2025

Grape-Pi: graph-based neural networks for enhanced protein identification in proteomics pipelines.

Chunhui Gu, Seyyed Mahmood Ghasemi, Yining Cai, Johannes F Fahrmann, James P Long, Hiroyuki Katayama, Chong Wu, Jody Vykoukal, Jennifer B Dennison, Samir Hanash and 2 more

Abstract read
In one paragraph

Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Chunhui GuDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
Seyyed Mahmood GhasemiDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
Yining CaiDepartment of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
Johannes F FahrmannDepartment of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
James P LongDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.ORCID https://orcid.org/0000-0001-5853-5938
Hiroyuki KatayamaDepartment of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.ORCID https://orcid.org/0000-0003-3117-1390
Chong WuDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.ORCID https://orcid.org/0000-0002-8400-1785
Jody VykoukalDepartment of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
Jennifer B DennisonDepartment of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
Samir HanashDepartment of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.ORCID https://orcid.org/0000-0002-4210-1593
Kim-Anh DoDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
Ehsan IrajizadDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.ORCID https://orcid.org/0000-0001-7510-4849

Funding

Clinical Validation Center for Lung Cancer Early DetectionU01CA271888 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HANASH, SAMIR M · 2022 to 2025
$4.9M
NCI NIH HHS U01 CA271888
6 · The paper itself

Abstract

Motivation: Protein identification via mass spectrometry (MS) is the primary method for untargeted protein detection. However, the identification process is challenging due to data complexity and the need to control false discovery rates (FDR) of protein identification. To address these challenges, we developed a graph neural network (GNN)-based model, Graph Neural Network using Protein-Protein Interaction for Enhancing Protein Identification (Grape-Pi), which is applicable to all proteomics pipelines. This model leverages protein-protein interaction (PPI) data and employs two types of message-passing layers to integrate evidence from both the target protein and its interactors, thereby improving identification accuracy. Results: Grape-Pi achieved significant improvements in area under receiver-operating characteristic curve (AUC) in differentiating present and absent proteins: 18% and 7% in two yeast samples and 9% in gastric samples over traditional methods in the test dataset. Additionally, proteins identified via Grape-Pi in gastric samples demonstrated a high correlation with mRNA data and identified gastric cancer proteins, like MAP4K4, missed by conventional methods. Availability and Implementation: Grape-Pi is freely available at https://zenodo.org/records/11310518 and https://github.com/FDUguchunhui/GrapePi.

Identifiers

PMID40406669
PMCPMC12096076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.